Depression is a consequence of drug abuse: Kangana Ranaut to Deepika Padukone

Ranaut made a jibe on the 'Padmaavat' star when latter's manager was reportedly summoned in the infamous drug case


Entertainment Desk September 22, 2020

Kangana Ranaut has taken a sarcastic jibe at Deepika Padukone, saying depression is a consequence of drug abuse. Kangana took to her verified Twitter account to take a dig at Deepika using the latter’s name in a hashtag, leaving no guesses as to who her comment was aimed at.

“Repeat after me, depression is a consequence of drug abuse. So-called high society rich star children who claim to be classy and have a good upbringing ask their manager,” Kangana tweeted. She went on to tag, #boycottBollywoodDruggies #DeepikaPadukone.

Ironically, Ranaut had earlier claim that she has a record of never starting a fight, and is ready to quit Twitter if anyone can prove otherwise.

 "I may come across as a very 'ladaku' person but it's not true, I have a record of never starting a fight, I will quit twitter if anyone can prove otherwise, I never start a fight but I finish every fight. God said when someone asks you to fight, you mustn't deny them,"

Just a day after Sushant Singh Rajput’s death, on June 15, Deepika had tweeted from her verified account: “Repeat after me: depression is an illness.” In another tweet posted on June 16, the actress had shared: “Repeat after me: depression is a form of mental illness.”

Kangana in her tweets has now taken a sarcastic jibe at Deepika using the latter’s catchwords in her anti-depression campaigns. Kangana’s jibe at Deepika comes after the news channel Times Now revealed a WhatsApp chat, which the channel claims allegedly took place between Deepika and her manager Karishma Prakash, who is reportedly an employee with Kwan Talent Management Agency.

Have something to add to the story? Share it in the comments below. 

COMMENTS

Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ